A carregar...
Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report
BACKGROUND: Molecular targeted therapies have dramatically improved the prognosis of metastatic renal cell carcinoma. However, patients in whom the treatment could initially be effective will experience disease progression later. CASE PRESENTATION: A 74-year-old Japanese man who was diagnosed with r...
Na minha lista:
| Publicado no: | J Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911686/ https://ncbi.nlm.nih.gov/pubmed/27312478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0961-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|